Kingmed

Chongqing, China · Founded 2019 · Privately Held (backing)

Developer of organoid solutions intended for the pharmaceutical industry. Kingmed is based in Chongqing, China and was founded in 2019.

Last price · $/share
—
Implied valuation
—
Total raised
—
Last round
—

Who backs Kingmed?

7 investors
InvestorType
TopoScend CapitalVenture capital
Fuyang Yingke Fund ManagementOther
Boji Pharmaceutical Technology—
Feixi County Industrial Park Investment Holding (Group)—
Jointown Pharmaceutical Group—
Ningbo Meishan Bonded Port Area Dingbo Equity Investment Management—
Qichen Capital Holdings (Zhuhai)—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Kingmed investors

7 investors are on record for Kingmed, including TopoScend Capital, Fuyang Yingke Fund Management, Boji Pharmaceutical Technology and Feixi County Industrial Park Investment Holding (Group).

Free account
More of Kingmed with a free account
  • ·Watch Kingmed: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 7 firms already write checks for companies like Kingmed. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View